Back
Context Therapeutics Vs. Collegium Pharmaceutical Industry Stock Comparison
Buy
66
CNTX
Context Therapeutics
Last Price:
2.26
Seasonality Move:
-23.73%
Buy
70
COLL
Collegium Pharmaceutical
Last Price:
39.12
Seasonality Move:
31.73%
Buy
66
Context Therapeutics (CNTX)
is a Buy
Is Context Therapeutics a Buy, Sell or Hold?
- The current Context Therapeutics [CNTX] share price is $2.25. The Score for CNTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CNTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Collegium Pharmaceutical (COLL)
is a Buy
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $39.10. The Score for COLL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- COLL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNTX Stock Price Chart
What is Context Therapeutics's stock price today?
-
The Context Therapeutics share price today is $2.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNTX is experiencing selling pressure, which indicates risk of future bearish movement.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $39.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing slight buying pressure.
CNTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 49.85 | Sell |
Chaikin Money Flow: | -385854 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.15 - 2.51) | Sell |
Bollinger Bands (100): | (1.83 - 2.37) | Buy |
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.67 | Buy |
Relative Strength Index (14 RSI): | 63.12 | Buy |
Chaikin Money Flow: | 281480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.13 - 38.25) | Buy |
Bollinger Bands (100): | (32.2 - 37.06) | Buy |
CNTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.12 | Buy |
20-day SMA: | 2.28 | Sell |
50-day SMA: | 2.3 | Sell |
200-day SMA: | 1.63 | Buy |
8-day EMA: | 2.16 | Buy |
20-day EMA: | 2.23 | Buy |
50-day EMA: | 2.23 | Buy |
200-day EMA: | 1.79 | Buy |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.69 | Buy |
20-day SMA: | 37.53 | Buy |
50-day SMA: | 35.96 | Buy |
200-day SMA: | 34.48 | Buy |
8-day EMA: | 38.07 | Buy |
20-day EMA: | 37.39 | Buy |
50-day EMA: | 36.24 | Buy |
200-day EMA: | 33.42 | Buy |
Context Therapeutics Earnings Growth & CNTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.14 per share, and a decrease next year of $0.02 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.10 per share, an increase this year of $0.99 per share, and an increase next year of $0.44 per share.
Context Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Collegium Pharmaceutical Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |